JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  June 2016

ACB-CLIN-CHEM-GEN June 2016

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: "B12 deficiency"

From:

Webster Craig <[log in to unmask]>

Reply-To:

Webster Craig <[log in to unmask]>

Date:

Tue, 21 Jun 2016 14:58:31 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (1 lines)

Hi



We can do a serum MMA mass spec assay. It's not currently ukas accredited and running it weekly as a research assay in final stages of validation.



Cheers

Craig



Dept Clinical Chemistry

Birmingham Heartlands Hospital



Sent from my iPhone



On 21 Jun 2016, at 15:32, Simon Olpin <[log in to unmask]<mailto:[log in to unmask]>> wrote:



Dear Clodagh,

we offer urine MMA/creatinine for £72. This is a useful marker in our experience and we do identify "deficient" patients in both the adult and more specifically the neonatal population not too infrequently. Most patients do respond biochemically to IM B12 within days. In infants often of vegan /vegetarian mothers, there is often prolonged jaundice & failure to thrive (sometimes more serious developmental delay) and in these there is generally a rapid clinical response to B12. Total homocysteine is sometimes raised in these patients with increased MMA but in my experience it is not as sensitive a marker although that may depend on the population under investigation. We will comment on B12 of <350 suggesting that this does not exclude B12 deficiency (particularly where there is clinical concern) & we suggest urine MMA as follow up. The haematological picture too can be relatively normal in some patients where there is evidence of peripheral neuropathy but raised MMA in urine.

Best wishes

Simon



Dr Simon Olpin PhD CSci FRCPath

Consultant Clinical Scientist in Inherited Metabolic Disease

Department of Clinical Chemistry

Sheffield Children's Hospital

Western Bank

Sheffield S10 2TH

 + 44 (0)114 2717267



>>> "Loughrey, Clodagh" <[log in to unmask]<mailto:[log in to unmask]>> 21/06/2016 14:52 >>>

Thanks, Simon, there does seem to be a consensus that plasma B12 in the low normal range (< 350 pcg/L) was suggested) may not be entirely reliable and in that scenario, with symptoms,  a plasma THcys would be a useful surrogate marker of intracellular B12 status, < 15 mmol/L putting it to bed. Would you recommend urine MMA as a more reliable marker than THCys, or save it for any ≥ 15mmol/L? Bearing in mind accessibility / cost.



C.



From: Simon Olpin [mailto:[log in to unmask]]

Sent: 21 June 2016 14:44

To: Loughrey, Clodagh; [log in to unmask]<mailto:[log in to unmask]>

Subject: Re: "B12 deficiency"



Hi Clodagh,

there is evidence to suggest that the B12 assays particularly towards the lower end may not accurately reflect tissue B12 status. Urine MMA is now generally considered to be a more sensitive marker of tissue B12 status than plasma B12. I would therefore be inclined to use urine MMA as the more reliable marker. Total plasma homocysteine may also be a sensitive marker for tissue B12 status in some patients although folate & riboflavin status also influence total homocysteine concentration.

Best wishes

Simon





Dr Simon Olpin PhD CSci FRCPath

Consultant Clinical Scientist in Inherited Metabolic Disease

Department of Clinical Chemistry

Sheffield Children's Hospital

Western Bank

Sheffield S10 2TH

 + 44 (0)114 2717267



>>> "Loughrey, Clodagh" <[log in to unmask]<mailto:[log in to unmask]>> 21/06/2016 12:26 >>>

Anyone encountered the situation below yet? This question is from one of our haematologists:



“We have had a couple of young female patients referred through our department recently who are of the unshakeable opinion that they require high doses of parenteral B12 (in one case she is self-administering on alternate days) to alleviate/prevent a variety of symptoms. I believe there are online forums specific to this issue. They are not reassured by the B12 assay and have been requesting additional assays/genetic tests.  Unfortunately the BSCH guideline on the subject of B12 leaves the duration rather open-ended for patients with neuropathy…although probably not the case here. Have you any experience of this? Understandably, their respective GPs are requesting advice.”



I am presuming they are looking for total homocysteine, urine MMA, IF antibodies, holotranscobalamin and / or cobalamin defect genetic testing.  I have advised that if the B12 (and Hb/ MCV) is within the reference range, there are no clinical features that could be in any way attributable to B12 deficiency, and there is no overt reason for them to have B12 deficiency (diet / alcohol / SB pathology etc), I don’t think any further laboratory testing is warranted. Particularly if they have already been receiving high doses of parenteral B12…



But I’m interested to know if others have encountered this and how you have advised.



Bw



Clodagh







CM Loughrey MD MRCP FRCPath MA

Consultant Chemical Pathologist

Clinical Director Laboratories

Belfast HSC Trust

Tel:  0044 28 950-48823









________________________________



This message contains information from Belfast Health And Social Care Trust which may be privileged and confidential.

If you believe you are not the intended recipient any disclosure, distribution or use of the contents is prohibited.

If you have received this message in error please notify the sender immediately.



This email has been scanned for the presence of computer viruses.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/





Sheffield Children's NHS Foundation Trust

Western Bank

Sheffield. S10 2TH

www: http://www.sheffieldchildrens.nhs.uk

The Children's Hospital Charity http://www.tchc.org.uk/

Donate here http://www.justgiving.com/tchc/donate



DISCLAIMER:

This e-mail (which also means any attachments) may contain confidential or privileged material. It is intended only for the addressee. If you have received this e-mail in error, please return it to the sender and delete the material from any computer system/backup.



Unless explicitly stated to the contrary, any views or opinions expressed are personal to the author and do not represent the views, opinions or policies of Sheffield Children's NHS Foundation Trust. This e-mail and its contents may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this e-mail and your reply cannot be guaranteed.



________________________________



This message contains information from Belfast Health And Social Care Trust which may be privileged and confidential.

If you believe you are not the intended recipient any disclosure, distribution or use of the contents is prohibited.

If you have received this message in error please notify the sender immediately.



This email has been scanned for the presence of computer viruses.





Sheffield Children's NHS Foundation Trust

Western Bank

Sheffield. S10 2TH

www: http://www.sheffieldchildrens.nhs.uk

The Children's Hospital Charity http://www.tchc.org.uk/

Donate here http://www.justgiving.com/tchc/donate



DISCLAIMER:

This e-mail (which also means any attachments) may contain confidential or privileged material. It is intended only for the addressee. If you have received this e-mail in error, please return it to the sender and delete the material from any computer system/backup.



Unless explicitly stated to the contrary, any views or opinions expressed are personal to the author and do not represent the views, opinions or policies of Sheffield Children's NHS Foundation Trust. This e-mail and its contents may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this e-mail and your reply cannot be guaranteed.

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk Green Laboratories Work http://www.laboratorymedicine.nhs.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/



------ACB discussion List Information--------

This is an open discussion list for the academic and clinical community working in clinical biochemistry.

Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.

ACB Web Site

http://www.acb.org.uk

Green Laboratories Work

http://www.laboratorymedicine.nhs.uk

List Archives

http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html

List Instructions (How to leave etc.)

http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager